Olanzapine-induced neuroleptic malignant syndrome.
暂无分享，去创建一个
[1] M. Cuesta,et al. Olanzapine in treatment-refractory schizophrenia: results of an open-label study. The Spanish Group for the Study of Olanzapine in Treatment-Refractory Schizophrenia. , 1997, The Journal of clinical psychiatry.
[2] G. Tollefson,et al. Extrapyramidal symptoms and tolerability of olanzapine versus haloperidol in the acute treatment of schizophrenia. , 1997, The Journal of clinical psychiatry.
[3] K. Goa,et al. Olanzapine. A review of its pharmacological properties and therapeutic efficacy in the management of schizophrenia and related psychoses. , 1997, Drugs.
[4] P. Sachdev,et al. Clozapine-induced neuroleptic malignant syndrome: review and report of new cases. , 1995, Journal of clinical psychopharmacology.
[5] M. Flaum,et al. Atypical Neuroleptic Malignant Syndrome (NMS) with an Atypical Neuroleptic Clozapine-induced NMS without Rigidity , 1990 .
[6] A. Lazarus,et al. Neuroleptic malignant syndrome. , 2000, Archives of general psychiatry.
[7] H. Pope,et al. Apparent neuroleptic malignant syndrome with clozapine and lithium. , 1986, The Journal of nervous and mental disease.